CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis
Frontiers in Immunology · 20.07.2026 · 17
DOI: 10.3389/fimmu.2026.1859932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 20.07.2026. Verfasst von Bochen Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Zhejiang Chinese Medical University(Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China. Hauptthemen laut MEDLINE: Receptors, CCR6, Chemokine CCL20, Liver Cirrhosis, Macrophages. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Zhejiang Traditional Chinese Medicine Administration, Zhejiang Chinese Medical University.
Abstract (Originalsprache)
Introduction
Cirrhosis is the end-stage of chronic liver disease characterized by progressive hepatic fibrosis and persistent immune dysregulation, yet the mechanisms by which immune cell crosstalk drives disease progression remain poorly understood.
Methods
In the present study, we integrated bulk and single-cell transcriptomic analyses with immunofluorescence validation to investigate the role of the CCL20-CCR6 axis in MAIT cells–macrophages interactions during cirrhosis progression.
Results
We identified eight core cirrhosis-associated immune genes ( OGN, IL32, CCL19, PDGFA, CCL20, NTS, SEMA3C, HSPA2 ), among which CCL20 was selectively enriched in mucosal-associated invariant T cells (MAIT) and closely associated with their activation- and exhaustion-related transcriptional profiles. Cell-cell communication analysis revealed that the CCL20-CCR6 axis may specifically mediate bidirectional interactions between MAIT cells and M2 macrophages, forming a disease-specific positive feedback loop within the cirrhotic microenvironment. Immunofluorescence staining further confirmed the enrichment and colocalization of CCL20, MAIT cells, and M2 macrophages in cirrhotic tissues.
Discussion
Collectively, these findings support the CCL20-CCR6 axis as a key regulator of hepatic immune dysregulation and fibrotic progression in liver cirrhosis, highlighting its potential as both a biomarker of disease activity and a therapeutic target for cirrhosis intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Zhejiang Chinese Medical University(Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
- Zhejiang Chinese Medical University School of Basic Medical Sciences, Hangzhou, China.
- The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- Zhejiang Traditional Chinese Medicine Administration
- Zhejiang Chinese Medical University
Zitieren
APA
Chen, B., Li, R., Zhang, S., Lou, Y., Zhang, S., Lou, J., Zhang, J., Xu, C., Jiang, T., & Lv, Y. (2026). CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1859932
Vancouver
Chen B, Li R, Zhang S, Lou Y, Zhang S, Lou J, et al. CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1859932
BibTeX
@article{Chen2026,
author = {Chen, Bochen and Li, Ruoling and Zhang, Shuya and Lou, Yiting and Zhang, Shuo and Lou, Jiaheng and Zhang, Jingcheng and Xu, Chuyun and Jiang, Tao and Lv, Yuanlin},
title = {CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1859932}
}
EUVIMED